D-index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
- PMID: 33590904
- PMCID: PMC8364926
- DOI: 10.1111/tid.13588
D-index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
Abstract
Background: Neutropenia is a risk factor for development of infections; however, the direct effect of neutropenia on development of bloodstream infection (BSI) is not known. D-index, which is area between the neutrophil time curve and a neutrophil count of 0.5 × 109 /L, incorporates the combined effect of severity and duration of neutropenia. We aimed to evaluate whether D-index can be used as a marker for BSI in patients with allogeneic stem cell transplantation.
Method: We conducted a retrospective cohort study of patients undergoing allogeneic stem cell transplantation between January 1, 2005, and September 30, 2015. The primary outcome measure was the development of BSI within 30 days of transplantation.
Results: A total of 714 patients were included in the study of whom 101 developed BSI. Patients with BSI had a significantly higher median D-index value compared with patients who did not have BSI (4990 vs. 3570, P < .001). As a marker, the performance of the D-index was similar to that of the duration of profound neutropenia (P = .18) and significantly better than the total duration of neutropenia (P = .001).
Conclusion: The D-index performed better than the total duration of neutropenia as a marker for BSI in patients with allogeneic stem cell transplantation. There was no difference between D-index and, a more easily calculable indicator, duration of profound neutropenia.
Keywords: D-index; allogeneic hematopoietic stem cell transplantation; bacteremia; bloodstream infection; neutropenia.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
Figures




References
-
- Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106(10):2258–2266. - PubMed
-
- Bodey GP, Buckley M, SATHE Y, FREIREICH EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of internal medicine. 1966;64(2):328–340. - PubMed
-
- van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167(4):441–452. - PubMed
-
- Freifeld AG, Bow EJ, Sepkowitz KA, et al.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56–93. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical